Related Experiment Video
Updated: Sep 26, 2026

Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects
Iris Gundel1, Gerald Weidinger1, Volker Ter Meulen1
1Institut für Virologie und Immunbiologie, Versbacher Str. 7, 97078 Würzburg, Germany.
Abstract:
Immunization via the oral route with an attenuated Yersinia enterocolitica strain expressing a fragment of the measles virus nucleocapsid protein (aa 79-161) via its type III protein secretion system induced a T helper type 1 response in immunized C3H mice, which conferred protection against measles virus-induced encephalitis in a time- and dose-dependent manner.
Insights
Oral immunization with a modified Yersinia enterocolitica strain expressing a measles virus protein fragment induced a protective T helper type 1 immune response in mice, offering defense against measles virus-induced encephalitis.
Area of Science:
- Immunology
- Virology
- Microbial Genetics
Background:
- Measles virus (MeV) causes severe encephalitis, a significant global health concern.
- Current MeV vaccines are effective but require parenteral administration.
- Developing alternative, orally deliverable vaccines is a key research objective.
Purpose of the Study:
- To evaluate the immunogenicity and protective efficacy of an orally administered, attenuated Yersinia enterocolitica vaccine candidate expressing a fragment of the MeV nucleocapsid protein (NCP).
- To investigate the type of immune response elicited by this novel vaccine strategy.
Main Methods:
- Construction of an attenuated Yersinia enterocolitica strain engineered to express a specific fragment (amino acids 79-161) of the MeV NCP using its type III secretion system.
- Oral immunization of C3H mice with the engineered Yersinia strain.
- Assessment of the induced immune response, specifically T helper type 1 (Th1) cell activity.
- Evaluation of protection against subsequent challenge with live measles virus, analyzing time- and dose-dependency.
Main Results:
- Oral immunization successfully induced a significant T helper type 1 (Th1) immune response in C3H mice.
- The induced Th1 response conferred a notable degree of protection against measles virus-induced encephalitis.
- Protection was observed to be dependent on both the dose of the vaccine administered and the time elapsed post-immunization.
Conclusions:
- An orally delivered, attenuated Yersinia enterocolitica vaccine vector expressing a measles virus NCP fragment is capable of eliciting a protective Th1 immune response.
- This novel oral immunization strategy shows promise for conferring protection against measles virus encephalitis, warranting further investigation.
More Related Videos
05:44A Rapid, Simple, and Standardized Homogenization Method to Prepare Antigen/Adjuvant Emulsions for Inducing Experimental Autoimmune Encephalomyelitis
Published on: December 9, 2022
08:03Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Published on: April 15, 2014
Related Concept Videos
Poliomyelitis
Vaccinations
Vaccines
Cross-reactivity
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Respiratory Syncytial Virus Disease